LGVN – longeveron inc. - class a common stock (US:NASDAQ)

News

Longeveron (LGVN) was upgraded by Wall Street Zen to "hold".
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.
Longeveron (LGVN) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com